Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases.
The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom.
Treatment of sleep disorders may improve fatigue in multiple sclerosis.
Cerebrospinal fluid proteomics: A new window for understanding human demyelinating disorders?
Pycnogenol Attenuates the Release of Proinflammatory Cytokines and Expression of Perilipin 2 in Lipopolysaccharide-Stimulated Microglia in Part via Inhibition of NF-κB and AP-1 Activation.
[Animal model of neuromyelitis optica].
MyelStones: the executive roles of myelin basic protein in myelin assembly and destabilization in multiple sclerosis.
Sulforaphane induces Nrf2 target genes and attenuates inflammatory gene expression in microglia from brain of young adult and aged mice.
Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model.
Teriflunomide.
Employment and multiple sclerosis in new zealand.
A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation.
Longitudinal changes in quality of life and related psychosocial variables in australians with multiple sclerosis.
Brain parenchymal fraction in an age-stratified healthy population - determined by MRI using manual segmentation and three automated segmentation methods.
Induction of regulatory T cells in Th1-/Th17-driven experimental autoimmune encephalomyelitis by zinc administration.
Increased apoptosis and hypomyelination in cerebral white matter of macular mutant mouse brain.
Cortical Damage and Disability in Multiple Sclerosis: Relation to Intracortical Inhibition and Facilitation.
Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response.
A longitudinal brain magnetic resonance imaging study of neuromyelitis optica spectrum disorder.
The Nuclear IκB Family Protein IκBNS Influences the Susceptibility to Experimental Autoimmune Encephalomyelitis in a Murine Model.
Multiple sclerosis; a disease of reproductive-aged women and the dilemma involving contraceptive methods.
Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.
A systematic review of drugs in late-stage development for the treatment of multiple sclerosis: a focus on oral synthetic drugs.
Association of interleukin 7 receptor gene polymorphism rs6897932 with multiple sclerosis patients in Khuzestan.
The level of viral infection of antigen-presenting cells is critical for the development of TMEV-induced demyelinating disease.
Pages
« first
‹ previous
…
635
636
637
638
639
640
641
642
643
…
next ›
last »